Published in Emerg Microbes Infect on May 06, 2015
C5a Receptor Expression - COVID-19 (C5-COV) (C5-COV) | NCT04369820
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | NCT04449588
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol (2016) 0.77
iTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice. Med Microbiol Immunol (2016) 0.76
Clinical Features and Radiological Findings of Adenovirus Pneumonia Associated with Progression to Acute Respiratory Distress Syndrome: A Single Center Study in 19 Adult Patients. Korean J Radiol (2016) 0.75
PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol (2016) 0.75
Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 11.31
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
H5N1 Virus Attachment to Lower Respiratory Tract. Science (2006) 6.34
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest (1977) 5.16
Preparing for the next pandemic. N Engl J Med (2005) 4.65
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 4.41
Role of C5a in inflammatory responses. Annu Rev Immunol (2005) 4.38
Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis (2005) 4.27
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00
The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest (2008) 3.90
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol (2004) 3.65
Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol (2012) 3.39
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity (2008) 3.36
Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One (2012) 3.13
Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ (2009) 2.89
Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis (1983) 2.63
Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood (2002) 2.62
The biology of influenza viruses. Vaccine (2008) 2.58
Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol (2011) 2.57
Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol (1992) 2.24
Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J Immunol (1994) 2.22
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol (1995) 2.06
Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest (1988) 1.99
An interferon-gamma-related cytokine storm in SARS patients. J Med Virol (2005) 1.83
Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest (1990) 1.79
Middle East respiratory syndrome coronavirus: implications for health care facilities. Am J Infect Control (2014) 1.73
NET balancing: a problem in inflammatory lung diseases. Front Immunol (2013) 1.61
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Clinical features and pathobiology of Ebolavirus infection. J Autoimmun (2014) 1.56
Role of C5a in multiorgan failure during sepsis. J Immunol (2001) 1.53
Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood (2005) 1.52
The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis (2013) 1.50
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med (2013) 1.48
Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol (2013) 1.46
Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol (1999) 1.42
Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys. Clin Infect Dis (2014) 1.40
Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis (2013) 1.40
Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol (2004) 1.36
Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med (2002) 1.35
Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis (2013) 1.34
Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis (2010) 1.33
Complement and viral pathogenesis. Virology (2011) 1.32
The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1--a review. Hum Pathol (2006) 1.30
Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol (1999) 1.30
Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J (2013) 1.26
Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation (1996) 1.25
Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol (2014) 1.25
Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol (1983) 1.21
Alternative complement pathway deregulation is correlated with dengue severity. PLoS One (2009) 1.20
Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci (1996) 1.19
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood (2003) 1.14
Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression. J Immunol (2000) 1.14
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J (2009) 1.07
Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm Res (2006) 1.06
Oxidative stress and free radicals in COPD--implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis (2014) 1.04
Production of C2 by human alveolar macrophages. Immunology (1978) 1.04
Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol (2006) 1.04
C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology (2000) 1.03
Influenza virus induces expression of antioxidant genes in human epithelial cells. Free Radic Biol Med (1994) 1.02
Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol (2004) 1.02
Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur J Immunol (1996) 1.00
Adult respiratory distress syndrome--I. Aetiology and mechanisms. Postgrad Med J (1984) 0.96
rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol (1999) 0.95
Gene expression profiles in peripheral blood mononuclear cells of SARS patients. World J Gastroenterol (2005) 0.95
Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently. Biochem J (1994) 0.94
Confronting potential influenza A (H5N1) pandemic with better vaccines. Emerg Infect Dis (2007) 0.94
Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS One (2013) 0.94
The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol (2009) 0.93
Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism. J Virol (2014) 0.93
Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp Mol Pathol (2012) 0.93
A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One (2011) 0.91
Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res (2005) 0.89
Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats. Int Immunopharmacol (2006) 0.89
H5N1 infection causes rapid mortality and high cytokine levels in chickens compared to ducks. Virus Res (2014) 0.88
Middle East Respiratory Syndrome-coronavirus infection: an overview. J Infect Public Health (2013) 0.88
Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol (2011) 0.88
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect (2011) 0.88
Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology (1996) 0.87
Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection. Am J Respir Cell Mol Biol (2013) 0.87
Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta Virol (2009) 0.86
Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules. J Virol (2014) 0.86
Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis. Clin Immunol (2010) 0.86
Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care (2013) 0.86
Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9. PLoS One (2014) 0.84
Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J Virol (2011) 0.84
Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells. Exp Dermatol (2001) 0.84
The Middle East respiratory syndrome--how worried should we be? MBio (2013) 0.84
Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells. PLoS One (2014) 0.83
Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors. Mol Immunol (2011) 0.82
Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection. Acta Pharmacol Sin (2013) 0.82
Neutrophils in chronic obstructive pulmonary disease. Novartis Found Symp (2001) 0.81
Cross-species transmission and emergence of novel viruses from birds. Curr Opin Virol (2015) 0.81
Impaired secretion of interferons by dendritic cells from aged subjects to influenza : role of histone modifications. Age (Dordr) (2012) 0.81
Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic. Semin Respir Crit Care Med (2013) 0.81
Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect (2012) 0.81
Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps. Expert Opin Ther Targets (2014) 0.81
Complement system in lung disease. Am J Respir Cell Mol Biol (2014) 0.78